Biotech

All Articles

' Professional intuition' led FDA experts to support Zevra's unusual illness med

.Zevra Therapeutics' uncommon ailment medicine seems to be to become on the course to permission thi...

Pfizer takes $230M attacked after axing stopped working DMD genetics therapy

.Pfizer's stage 3 Duchenne muscle dystrophy (DMD) genetics treatment failure has actually gone a $23...

AC Immune observes 'landmark' prospective in Alzheimer's medication records

.After much more than 20 years of deal with neurodegenerative conditions, Swiss biotech AC Invulnera...

GSK loses ph. 2 HPV vaccine over shortage of best-in-class possible

.GSK has actually scrapped a period 2 individual papillomavirus (HPV) vaccine coming from its own pi...

OS Therapies refiles $6M IPO to money HER2 medication, preclinical ADCs

.OS Therapies will specify on the NYSE American supply exchange today through a $6.4 thousand IPO th...

ALX's fizzling CD47 feedback price sends sell spiraling down

.ALX Oncology's phase 2 stomach cancer reaction price has weakened. After finding its CD47 blocker s...

Ionis axes eye disease coming from intendeds of Roche-partnered prospect after data let down

.An Additional of Ionis Pharmaceuticals' key midphase readouts has disappointed assumptions, prompti...

Biogen's CEO stated no dangerous handle 2023. He's ready to be strong

.While Biogen's pharma peers are actually hunting for late-stage properties with little risk, chief ...

Instil refills pipe in $2B biobucks cope with ImmunOnco

.Instil Bio has been a biotech searching for a pipe after it junked its own lead resources over the ...

Biogen leaves Denali Alzheimer's collab

.Biogen has restored civil rights to a very early Alzheimer's ailment program to Denali Rehabs, leav...